Real-time enrollment status for this chronic urticaria clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 6:55 AM UTC
| NCT Number | NCT05677451 |
| Recruiting Status | Recruiting |
| Condition | Chronic Urticaria |
| Phase | PHASE3 |
| Target Enrollment | 100 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | June 5, 2026 (Jun 5, 2026) |
As of July 18, 2026: Clinical trial NCT05677451 is currently recruiting participants. This phase3 study for chronic urticaria is actively seeking new participants at 12 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05677451 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05677451 was last updated Jun 5, 2026 (June 5, 2026). HelloStudys verifies this status automatically.